These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37544625)

  • 21. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National Trends in the Burden of Atrial Fibrillation During Hospital Admissions for Heart Failure.
    Reinhardt SW; Chouairi F; Miller PE; Clark KAA; Kay B; Fuery M; Guha A; Freeman JV; Ahmad T; Desai NR; Friedman DJ
    J Am Heart Assoc; 2021 Jun; 10(11):e019412. PubMed ID: 34013736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Nicoli CD; O'Neal WT; Levitan EB; Singleton MJ; Judd SE; Howard G; Safford MM; Soliman EZ
    Heart; 2022 Mar; 108(5):353-359. PubMed ID: 34031160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.
    Naccarelli GV; Johnston SS; Dalal M; Lin J; Patel PP
    Am J Cardiol; 2012 Feb; 109(4):543-9. PubMed ID: 22118826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure.
    Gierula J; Cole CA; Drozd M; Lowry JE; Straw S; Slater TA; Paton MF; Byrom RJ; Garland E; Halliday G; Winsor S; Lyall GK; Birch K; McGinlay M; Sunley E; Grant PJ; Wessels DH; Ketiar EM; Witte KK; Cubbon RM; Kearney MT
    ESC Heart Fail; 2022 Oct; 9(5):3254-3263. PubMed ID: 35790085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes.
    Kotecha D; Chudasama R; Lane DA; Kirchhof P; Lip GY
    Int J Cardiol; 2016 Jan; 203():660-6. PubMed ID: 26580351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethnic differences in atrial fibrillation among patients with heart failure in Asia.
    Tan ESJ; Goh V; Santema BT; Tay WT; Teng TK; Yap J; Tromp J; Hung CL; Chopra V; Anand I; MacDonald MR; Ling LH; ; Van Gelder IC; Rienstra M; Voors AA; Richards AM; Lam CSP
    ESC Heart Fail; 2020 Aug; 7(4):1419-1429. PubMed ID: 32383559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE-AF registry.
    Contreras JP; Hong KN; Castillo J; Marzec LN; Hsu JC; Cannon CP; Yang S; Maddox TM
    Clin Cardiol; 2019 Mar; 42(3):339-345. PubMed ID: 30582177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.
    Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA
    J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute kidney injury: a clinical issue in hospitalized patients with heart failure with mid-range ejection fraction.
    Lala RI; Lungeanu D; Puschita M; Pop-Moldovan A; Darabantiu D
    Pol Arch Intern Med; 2018 Dec; 128(12):746-754. PubMed ID: 30411719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets.
    Peigh G; Shah SJ; Patel RB
    Curr Heart Fail Rep; 2021 Jun; 18(3):85-98. PubMed ID: 33864224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.
    Chamberlain AM; Gersh BJ; Alonso A; Kopecky SL; Killian JM; Weston SA; Roger VL
    Heart Rhythm; 2017 Jun; 14(6):791-798. PubMed ID: 28119130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and impact of pulmonary hypertension on acute decompensated heart failure with preserved ejection fraction hospitalizations: A five-year retrospective analysis.
    Wahadneh OA; Alitter Q; Raju A; Alziadin N; Alshurafa AH; Aldabbas HO; Shaik I
    Curr Probl Cardiol; 2024 Jun; 49(6):102537. PubMed ID: 38522770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
    Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
    JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.